Medications

FDA approves first-in-class treatment for myasthenia gravis

(HealthDay)—Vyvgart (efgartigimod), a neonatal Fc receptor blocker (FcRn), was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor (AChR) antibody, the U.S. Food ...

Diseases, Conditions, Syndromes

Infection risk does not seem to differ among biologics for psoriasis

(HealthDay)—Among biologics used for the treatment of psoriasis, there do not appear to be differential risks for serious infection or respiratory tract infection, according to a study presented at the annual meeting of ...

Diseases, Conditions, Syndromes

Respiratory virus detections decreased during COVID-19

(HealthDay)—Respiratory virus detections decreased during the COVID-19 pandemic period, according to a research letter published online June 21 in JAMA Internal Medicine.

page 3 from 16